Bronchodilator response as an independent predictor of severity in bronchiectasis. [PDF]
Kang YR +12 more
europepmc +1 more source
Risk of Hospitalized COVID-19 in COPD: Single-Inhaler Triple Versus Dual Bronchodilator Therapy. [PDF]
Galmiche S, Dell'Aniello S, Suissa S.
europepmc +1 more source
Therapies for bronchiectasis: mechanisms and potential effects. [PDF]
Yu L, Zhu HR, Jin XH, Ding J, Jin T.
europepmc +1 more source
A multifactorial model for chronic obstructive pulmonary disease risk in smokers with positive bronchodilation: a retrospective cohort study. [PDF]
Zhang J +15 more
europepmc +1 more source
GOLD 2026: Transforming COPD Management with Early Intervention, Multi-dimensional Assessment, and Personalized Care. [PDF]
Cazzola M +4 more
europepmc +1 more source
Advances in the Association Between the <i>ADRB2</i> Gene and Bronchial Asthma: Genetic Polymorphisms, Epigenetic Regulation, and Clinical Applications. [PDF]
Sun X, Li Y, Bao Y.
europepmc +1 more source
Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 - mapping retrospective data. [PDF]
Kojen AJ +5 more
europepmc +1 more source
Assessment of ventilation distribution in overweight and obese children with asthma using electric impedance tomography: a cross-sectional study. [PDF]
Gambadauro A +8 more
europepmc +1 more source
Temporal and Partial Reversal of Airflow Limitation in Patients With COPD Treated With Single-Inhaler Long-Acting Dual Bronchodilators. [PDF]
Lu Y +10 more
europepmc +1 more source
Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease. [PDF]
Siler TM +5 more
europepmc +1 more source

